Bridgeway Capital Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$388K Hold
59,579
0.01% 870
2025
Q4
$341K Hold
59,579
0.01% 899
2025
Q3
$406K Buy
59,579
+18,400
+45% +$139K 0.01% 848
2025
Q2
$370K Hold
41,179
0.01% 824
2025
Q1
$222K Sell
41,179
-32,700
-44% -$222K 0.01% 906
2024
Q4
$550K Sell
73,879
-7,231
-9% -$59.5K 0.01% 793
2024
Q3
$733K Sell
81,110
-19,226
-19% -$198K 0.02% 760
2024
Q2
$1.07M Buy
100,336
+2,340
+2% +$24.9K 0.02% 658
2024
Q1
$863K Buy
97,996
+2,275
+2% +$18.5K 0.02% 779
2023
Q4
$653K Sell
95,721
-7,504
-7% -$61.6K 0.01% 871
2023
Q3
$1.01M Sell
103,225
-50,359
-33% -$404K 0.02% 708
2023
Q2
$743K Sell
153,584
-24,181
-14% -$105K 0.02% 801
2023
Q1
$715K Sell
177,765
-1,235
-0.7% -$4.96K 0.02% 801
2022
Q4
$691K Sell
179,000
-30,000
-14% -$138K 0.02% 815
2022
Q3
$1M Hold
209,000
0.03% 734
2022
Q2
$951K Hold
209,000
0.02% 736
2022
Q1
$1.12M Buy
209,000
+85,000
+69% +$455K 0.02% 753
2021
Q4
$749K Buy
124,000
+15,000
+14% +$92.1K 0.01% 858
2021
Q3
$771K Hold
109,000
0.01% 908
2021
Q2
$913K Sell
109,000
-12,300
-10% -$106K 0.02% 889
2021
Q1
$1M Buy
121,300
+30,000
+33% +$213K 0.02% 863
2020
Q4
$591K Hold
91,300
0.01% 891
2020
Q3
$539K Hold
91,300
0.01% 859
2020
Q2
$640K Hold
91,300
0.01% 790
2020
Q1
$475K Buy
91,300
+7,700
+9% +$52.7K 0.01% 782
2019
Q4
$618K Hold
83,600
0.01% 897
2019
Q3
$724K Buy
83,600
+4,600
+6% +$39.4K 0.01% 822
2019
Q2
$628K Sell
79,000
-98,000
-55% -$892K 0.01% 902
2019
Q1
$1.82M Hold
177,000
0.02% 564
2018
Q4
$1.2M Sell
177,000
-25,000
-12% -$182K 0.02% 669
2018
Q3
$1.65M Sell
202,000
-35,000
-15% -$327K 0.02% 689
2018
Q2
$2.27M Hold
237,000
0.02% 591
2018
Q1
$2.37M Hold
237,000
0.03% 531
2017
Q4
$1.55M Hold
237,000
0.02% 669
2017
Q3
$1.6M Buy
237,000
+31,000
+15% +$211K 0.02% 668
2017
Q2
$1.48M Buy
206,000
+73,700
+56% +$451K 0.02% 678
2017
Q1
$714K Hold
132,300
0.01% 935
2016
Q4
$655K Hold
132,300
0.01% 972
2016
Q3
$542K Sell
132,300
-46,700
-26% -$205K 0.01% 1062
2016
Q2
$897K Hold
179,000
0.01% 817
2016
Q1
$916K Hold
179,000
0.02% 808
2015
Q4
$1.16M Hold
179,000
0.02% 695
2015
Q3
$1.05M Buy
179,000
+10,600
+6% +$47.3K 0.02% 725
2015
Q2
$706K Buy
168,400
+88,500
+111% +$360K 0.01% 919
2015
Q1
$319K Hold
79,900
0.01% 1239
2014
Q4
$250K Buy
79,900
+62,400
+357% +$192K 0.01% 1259
2014
Q3
$57K Buy
17,500
+1,200
+7% +$4.12K ﹤0.01% 1453
2014
Q2
$63K Hold
16,300
﹤0.01% 1417
2014
Q1
$69K Hold
16,300
﹤0.01% 1399
2013
Q4
$58K Hold
16,300
﹤0.01% 1375
2013
Q3
$65K Hold
16,300
﹤0.01% 1400
2013
Q2
$58K Buy
+16,300
New +$63.6K ﹤0.01% 1376

Other funds holding ULBI

Bridgeway Capital Management's ULBI Position: Q1 2026 in Review

Bridgeway Capital Management held its Ultralife (ULBI) position steady in Q1 2026 at 59,579 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #870.

Bridgeway Capital Management first reported a position in ULBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.37M in Q1 2018. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Bridgeway Capital Management held 59,579 shares of Ultralife worth $388K as of Q1 2026.
  • Bridgeway Capital Management left its Ultralife share count unchanged in Q1 2026.
  • Ultralife made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #870 holding.
  • Bridgeway Capital Management first reported a position in Ultralife in Q2 2013 and has held it in 52 quarters since.
  • Bridgeway Capital Management's Ultralife position peaked at $2.37M in Q1 2018.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.